1. Home
  2. CSPI vs IXHL Comparison

CSPI vs IXHL Comparison

Compare CSPI & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSP Inc.

CSPI

CSP Inc.

HOLD

Current Price

$8.23

Market Cap

107.1M

Sector

Technology

ML Signal

HOLD

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$2.96

Market Cap

97.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSPI
IXHL
Founded
1968
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
107.1M
97.6M
IPO Year
1994
2024

Fundamental Metrics

Financial Performance
Metric
CSPI
IXHL
Price
$8.23
$2.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.3K
3.5M
Earning Date
02-12-2026
02-13-2026
Dividend Yield
1.44%
N/A
EPS Growth
75.00
N/A
EPS
0.01
N/A
Revenue
$58,730,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$823.00
N/A
Revenue Growth
6.36
N/A
52 Week Low
$8.04
$0.11
52 Week High
$17.76
$6.39

Technical Indicators

Market Signals
Indicator
CSPI
IXHL
Relative Strength Index (RSI) 32.42 53.79
Support Level $8.04 $2.85
Resistance Level $12.78 $5.17
Average True Range (ATR) 0.38 0.47
MACD 0.03 -0.19
Stochastic Oscillator 10.44 4.52

Price Performance

Historical Comparison
CSPI
IXHL

About CSPI CSP Inc.

CSP Inc develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments, namely Technology Solutions, where the company focuses on value-added reseller integrated solutions, including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company designs, manufactures, and delivers products and services to customers that require specialized cybersecurity services, networking, and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates the majority of its revenue from the Americas.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: